Ensign Peak Advisors’s Tandem Diabetes Care TNDM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Sell |
24,982
-550
| -2% | -$10.3K | ﹤0.01% | 1576 |
|
|
2025
Q1 | $489K | Hold |
25,532
| – | – | ﹤0.01% | 1559 |
|
|
2024
Q4 | $920K | Hold |
25,532
| – | – | ﹤0.01% | 1370 |
|
|
2024
Q3 | $1.08M | Hold |
25,532
| – | – | ﹤0.01% | 1272 |
|
|
2024
Q2 | $1.03M | Hold |
25,532
| – | – | ﹤0.01% | 1257 |
|
|
2024
Q1 | $904K | Sell |
25,532
-1,288
| -5% | -$45.6K | ﹤0.01% | 1398 |
|
|
2023
Q4 | $793K | Buy |
26,820
+4,200
| +19% | +$124K | ﹤0.01% | 1508 |
|
|
2023
Q3 | $470K | Hold |
22,620
| – | – | ﹤0.01% | 1610 |
|
|
2023
Q2 | $555K | Hold |
22,620
| – | – | ﹤0.01% | 1605 |
|
|
2023
Q1 | $919K | Buy |
22,620
+50
| +0.2% | +$2.03K | ﹤0.01% | 1309 |
|
|
2022
Q4 | $1.01M | Buy |
22,570
+5,900
| +35% | +$265K | ﹤0.01% | 1151 |
|
|
2022
Q3 | $798K | Hold |
16,670
| – | – | ﹤0.01% | 1197 |
|
|
2022
Q2 | $987K | Buy |
16,670
+1,690
| +11% | +$100K | ﹤0.01% | 1113 |
|
|
2022
Q1 | $1.74M | Hold |
14,980
| – | – | ﹤0.01% | 939 |
|
|
2021
Q4 | $2.26M | Buy |
14,980
+2,080
| +16% | +$313K | ﹤0.01% | 919 |
|
|
2021
Q3 | $1.53M | Buy |
+12,900
| New | +$1.53M | ﹤0.01% | 1256 |
|
|
2021
Q1 | – | Sell |
-2,679
| Closed | -$256K | – | 1882 |
|
|
2020
Q4 | $256K | Buy |
2,679
+576
| +27% | +$55K | ﹤0.01% | 1694 |
|
|
2020
Q3 | $239K | Sell |
2,103
-482
| -19% | -$54.8K | ﹤0.01% | 1653 |
|
|
2020
Q2 | $256K | Hold |
2,585
| – | – | ﹤0.01% | 1557 |
|
|
2020
Q1 | $166K | Buy |
+2,585
| New | +$166K | ﹤0.01% | 1546 |
|